clarithromycin has been researched along with amoxicillin-potassium clavulanate combination in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (19.61) | 18.2507 |
2000's | 20 (39.22) | 29.6817 |
2010's | 15 (29.41) | 24.3611 |
2020's | 6 (11.76) | 2.80 |
Authors | Studies |
---|---|
Chonmaitree, T; Hedgpeth, D; Horlick, D; Howie, VM; Owen, MJ; Patel, JA | 1 |
Larsson, AJ; Rotschafer, JC; Walker, KJ; Zabinski, RA | 1 |
Dubois, J; Saint-Pierre, C; Tremblay, C | 1 |
Davies, BI; Dirks-Go, SI; Hoogkamp-Korstanje, JA; Kabel, P; Manson, WL; Stobberingh, EE; Vreede, RW | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
de Torrenté, A; Genné, D; Humair, L; Janin-Jaquat, B; Siegrist, HH | 1 |
Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Berry, V; Knott, SJ; Thorburn, CE; Woodnutt, G | 1 |
Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR | 1 |
Danziger, LH; Jung, R; Losendahl, KJ; Messick, CR; Pendland, SL; Schriever, CA; Tesoro, EP | 1 |
Goss, TF; Najib, MM; Stein, GE | 1 |
Hammerschlag, MR | 1 |
Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
Anzueto, A; Busman, T; Fisher, CL; Olson, CA | 1 |
Garcia-Motos, C; Martínez-Ramírez, M; Montesinos-Ros, A; Navarro-Ruiz, A; Sendra, P | 1 |
Bobbaers, H; Collins, O; Finch, R; Hoeffken, G; Izquierdo, JL; Kubin, R; McGivern, J; Nikolaides, P; Ogundare, F; Raz, R; Schürmann, D; Zuck, P | 1 |
Appelbaum, PC; Bozdogan, B; Clark, C; Dewasse, B; Jacobs, MR; Peric, M | 1 |
Bodasing, N; Kennedy, D | 1 |
Becker, DL; Chancellor, JV; Drummond, MF; Duprat-Lomon, I; Hux, M; Kubin, R; Sagnier, PP | 1 |
Gasbarrini, A; Gasbarrini, G; Migneco, A; Nista, EC; Ojetti, V; Zocco, MA | 1 |
Corey, JP; Houser, SM; Mamikoglu, B; Moinuddin, R; Rechtweg, JS | 1 |
Applebaum, PC; Beratis, NG; Bozdogan, B; Ednie, LM; Grivea, IN; Katopodis, GD; Kritikou, DI; Syrogiannopoulos, GA | 1 |
García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A | 1 |
Busman, TA; Palmer, R; Riffer, E; Shortridge, V; Spiller, J; Valdes, J | 1 |
Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K | 1 |
Balatsouras, DG; Homsioglou, E; Kouskoukis, C; Rallis, E; Verros, C | 1 |
De Vecchi, E; Drago, L; Nicola, L; Zucchetti, E | 1 |
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
Dorshimer, GW; Kim, PK | 1 |
Bargiacchi, O; Brondolo, R; Brustia, D; Garavelli, PL; Rizzo, G; Salerno, AM | 1 |
Abdullah, MF; O'Connor, MB; O'Donovan, N; Phelan, MJ | 1 |
Al-Abri, SS; Al-Maashani, S; Beeching, NJ; Memish, ZA | 1 |
Akermanis, M; Dimiņa, E; Dumpis, U; Tirāns, E; Veide, S | 1 |
Harvey, E; Varatharaj, A | 1 |
Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ | 1 |
Chan, KA; Chang, CH; Chou, HW; Lai, CL; Lai, MS; Wang, JL | 1 |
Gerek, M; Gumral, R; Kilic, A; Polat, B; Tosun, F; Yildizoglu, U | 1 |
Balakrishnan, T; Davies, G; Ka Ho Lee, P; Krishnamoorthy, S; Moore, A | 1 |
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Achar, J; Bobokhojaev, OI; du Cros, P; Dusmatova, Z; Quinnell, S; Seddon, JA; Swaminathan, A | 1 |
Bannister, CA; Berni, E; Butler, CC; Currie, CJ; de Voogd, H; Halcox, JP; Jenkins-Jones, S; Jones, B; Ouwens, M | 1 |
Chornyy, V; Kazory, A; Koratala, A | 1 |
Aubry, A; Bouchet, F; Lavigne, JP; Martin, B; Sotto, A; Veziris, N | 1 |
Cao, C; Chen, M; Ding, H; Hu, D; Lao, X; Ning, Q; Pang, Y; Xu, X; Zang, N; Zhang, C; Zou, J | 1 |
Debie, G; Horoi, M; Kampouridis, S; Lechien, JR; Mahillon, V; Muls, V; Rodriguez, A; Saussez, S; Thill, MP | 1 |
D'Errico, MM; De Cosmo, S; Mirijello, A; Piscitelli, P | 1 |
Begbey, A; Guppy, JH; Mohan, C; Webster, S | 1 |
Agius, JE; Emery, JP; Phalen, DN; Rose, K | 1 |
Ambrosetti, J; Besson, M; Bondolfi, G; Costanza, A; Meszaros, EP; Sarasin, F; Stancu, C | 1 |
Addo, J; Anagonou, ES; Ayelo, AG; Biswas, N; Calderon, F; Cruz, I; Della Pasqua, O; Díez, G; Gine-March, A; Gnimavo, RS; Herrador, Z; Houezo, JG; Johnson, RC; Kpoton, GG; Mendoza-Losana, A; Mignanwande, FZ; Orford, L; Ramón-García, S; Sáez-López, E; Sopoh, GE; Vlasakakis, G | 1 |
1 review(s) available for clarithromycin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Hallucinations with therapeutic doses of clarithromycin.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anxiety; Clarithromycin; Dizziness; Female; Hallucinations; Humans; Respiratory Tract Infections | 2002 |
13 trial(s) available for clarithromycin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Effect of viral respiratory tract infection on outcome of acute otitis media.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefpodoxime; Ceftizoxime; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Treatment Outcome; Virus Diseases | 1992 |
Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Bacterial Infections; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Single-Blind Method; Treatment Outcome | 1993 |
Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1997 |
Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Clarithromycin; Female; Humans; Male; Middle Aged; Tablets | 2001 |
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment.
Topics: Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines | 2002 |
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; beta-Lactamases; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance | 2004 |
Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Quality of Life; Rhinitis, Allergic, Perennial; Severity of Illness Index; Single-Blind Method; Sinusitis; Surveys and Questionnaires | 2004 |
Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
Topics: Acute Disease; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Penicillin V; Pharyngitis; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2004 |
Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Single-Blind Method; Sinusitis; Treatment Outcome | 2005 |
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Drug Therapy, Combination; Epidemiologic Methods; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Oxygen Inhalation Therapy; Prognosis; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome | 2005 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
A 10-Year Follow-Up of a Randomized Prospective Study of 2 Treatments for Chronic Rhinosinusitis Without Nasal Polyps and Investigation of the Impact of Gastroeosophageal Reflux Disease in the Resistance to Treatment.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Middle Aged; Patient Acuity; Rhinitis; Sino-Nasal Outcome Test; Sinusitis; Steroids | 2021 |
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled mu
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benin; Buruli Ulcer; Clarithromycin; Clinical Trials, Phase II as Topic; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome | 2022 |
37 other study(ies) available for clarithromycin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clarithromycin; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Haemophilus influenzae; Humans; Kinetics; Microbial Sensitivity Tests; Models, Biological | 1994 |
Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Clavulanic Acids; Drug Evaluation; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Quinolones; Streptococcus pneumoniae | 1997 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 1998 |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; beta-Lactamases; Clarithromycin; Clindamycin; Drug Therapy, Combination; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Ketolides; Macrolides; Metronidazole; Microbial Sensitivity Tests; Roxithromycin; Virginiamycin | 1999 |
Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxy-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteroides fragilis; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Peptostreptococcus | 2000 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
Treatment of Chlamydia pneumoniae.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Pneumonia, Bacterial | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
Topics: Amino Acid Sequence; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Genes, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial | 2002 |
Moraxella catarrhalis bacteraemia associated with Mycoplasma pneumoniae infection and pneumonia.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Breast Neoplasms; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gram-Negative Bacterial Infections; Humans; Moraxella catarrhalis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma | 2002 |
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fluoroquinolones; France; Germany; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Randomized Controlled Trials as Topic | 2003 |
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial | 2005 |
Drug eruptions in children with ENT infections.
Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Child, Preschool; Clarithromycin; Clindamycin; Diagnosis, Differential; Drug Eruptions; Erythromycin; Female; Humans; Infant; Infections; Male; Otitis; Otorhinolaryngologic Diseases; Pharyngitis; Prospective Studies; Rhinitis; Risk Factors; Sinusitis; Stomatognathic Diseases; Tonsillitis | 2006 |
In vitro induction of resistance by tissue concentrations of azithromycin, clarithromycin, cefixime and amoxicillin/clavulanate in clinical isolates of Streptococcus pyogenes.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefixime; Cells, Cultured; Clarithromycin; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Streptococcus pyogenes | 2006 |
Case report: peptic ulcer disease in a professional athlete.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Football; Humans; Male; Medical History Taking; Omeprazole; Peptic Ulcer; Risk Factors; Young Adult | 2009 |
[Whipple's disease in an AIDS patient with Kaposi's sarcoma. Report of a case].
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clarithromycin; Duodenum; Humans; Male; Sarcoma, Kaposi; Skin Neoplasms; Tropheryma; Whipple Disease | 2010 |
Rituximab-induced pulmonary disease.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis; Clarithromycin; Drug Therapy, Combination; Humans; Hydrocortisone; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Rituximab; Treatment Outcome | 2012 |
An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Disease Management; Female; Guideline Adherence; Hospitalization; Humans; Male; Medical Audit; Middle Aged; Oman; Pneumonia; Practice Guidelines as Topic; Quality of Health Care; Retrospective Studies; Severity of Illness Index | 2012 |
Assessment of antibiotic prescribing in Latvian general practitioners.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Child; Child, Preschool; Clarithromycin; Drug Prescriptions; Female; General Practice; Humans; Infant; Latvia; Male; Middle Aged; Pharyngitis; Pneumonia; Practice Patterns, Physicians'; Sinusitis; Surveys and Questionnaires; Urinary Tract Infections; Young Adult | 2013 |
Round pneumonia.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Pneumonia, Bacterial; Tomography, X-Ray Computed | 2014 |
Salvage therapy for multidrug-resistant tuberculosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; beta-Lactamase Inhibitors; Cardiovascular Diseases; Ciprofloxacin; Clarithromycin; Comorbidity; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Moxifloxacin; Risk; Taiwan | 2015 |
Effect of antibiotic use on bacterial flora of tonsil core in patients with recurrent tonsillitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Chemoprevention; Child; Chronic Disease; Clarithromycin; Female; Humans; Male; Palatine Tonsil; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Recurrence; Tonsillectomy; Tonsillitis; Turkey; Viridans Streptococci | 2015 |
Weil's disease presenting as atypical pneumonia.
Topics: Acute Kidney Injury; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Fluid Therapy; Humans; Jaundice; Leptospira; Lung; Male; Middle Aged; Oxygen Inhalation Therapy; Pneumonia, Mycoplasma; Radiography; Serologic Tests; Treatment Outcome; Weil Disease | 2014 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Clofazimine; Drug Combinations; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Linezolid; Male; Retrospective Studies; Sputum; Tajikistan; Treatment Outcome | 2016 |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; United Kingdom | 2017 |
Exit Site Infection in Peritoneal Dialysis; Need for Follow-Up on Cultures Despite Clinical Improvement.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacterial Typing Techniques; Clarithromycin; Diabetes Mellitus; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis; Surgical Wound Infection | 2017 |
Should single antibiotic therapy be avoided for nontuberculous mycobacteria?
Topics: Adult; Agricultural Workers' Diseases; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Contraindications, Drug; Drug Resistance, Bacterial; Drug Substitution; Finger Injuries; Humans; Male; Mycobacterium Infections, Nontuberculous; Occupational Injuries; Tenosynovitis; Trimethoprim, Sulfamethoxazole Drug Combination; Wound Infection | 2017 |
Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-γ autoantibody formation.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Autoantibodies; Clarithromycin; Ethambutol; Female; Granuloma; Humans; Interferon-gamma; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Scalp; Soft Tissue Infections | 2019 |
Electrocardiographic alterations and raised procalcitonin levels during anaphylactic shock.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anaphylaxis; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Electrocardiography; Female; Humans; Hydrocortisone; Middle Aged; Procalcitonin | 2020 |
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Comorbidity; Crohn Disease; Enterobacteriaceae Infections; Female; Hafnia alvei; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Rare Diseases; Treatment Outcome; Young Adult | 2020 |
Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Models, Animal; Enrofloxacin; Enterococcus; Humans; Lizards | 2021 |
Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separately.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Mania; Middle Aged; Quality of Life | 2021 |